We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
The retina sub-specialism is a branch of ophthalmology concerned with studying, diagnosing and treating retina, uvea and vitreous conditions.
Among the pathologies tackled by this sub-specialism are pathologies of the retina that require medical treatment, including: diabetic retinopathy, retinal vascular disorder, such as venous thrombosis or arterial occlusions, age-associated macular degeneration or severe myopia.
The Department has the most advanced technology for the surgical treatment of various retina conditions:
The Department also has the technology required for correct differential diagnosis of tumour pathologies of the eye and to conduct multi-disciplinary exams to diagnose and monitor patients. With regard to treating choroidal melanoma, the Department performs treatment through vitrectomy, acquiring tumour samples, and through tumour endoresection, as well as plaque brachytherapy implant (local radiotherapy).
The Retina Department at Vall d'Hebron Hospital constantly works on implementing and updating protocols of action on the different diseases of the retina and vitreous. The Retina Department is highly committed to research and teaching. It stands out for its long tradition of publications and for publishing chapters in books, as well as for taking part in various national and international studies on the latest scientific advances and technological innovation, allowing us to offer our patients the latest therapeutic advances.
The clinical and basic research activity of the ophthalmology research group focuses on finding new treatments for blindness. We have a research programme in developing new therapeutic strategies based on: a) gene and cell therapies to regenerate or halt the retina degeneration process in pre-clinical models; b) eyewash formulae to discover new anti-inflammatory and anti-oxidant compounds to treat retina conditions; and c) 3D retinal organoids derived from hiPSC and bioscaffolds used as models of retinal disease, both for genome editing and drug screening.
Ophthalmology
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.